MARKET

TNGX

TNGX

Tango Therapeutics Inc
NASDAQ
1.650
-0.090
-5.17%
Opening 11:57 03/25 EDT
OPEN
1.750
PREV CLOSE
1.740
HIGH
1.750
LOW
1.645
VOLUME
150.67K
TURNOVER
--
52 WEEK HIGH
12.02
52 WEEK LOW
1.645
MARKET CAP
178.38M
P/E (TTM)
-1.3831
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TNGX last week (0317-0321)?
Weekly Report · 1d ago
Barclays Sticks to Its Buy Rating for Tango Therapeutics (TNGX)
TipRanks · 1d ago
Weekly Report: what happened at TNGX last week (0310-0314)?
Weekly Report · 03/17 12:21
Weekly Report: what happened at TNGX last week (0303-0307)?
Weekly Report · 03/10 12:23
Weekly Report: what happened at TNGX last week (0224-0228)?
Weekly Report · 03/03 12:21
Tango Therapeutics: Promising Efficacy and Strategic Expansion Justify Buy Rating
TipRanks · 03/03 06:58
Tango Therapeutics (TNGX) Receives a Buy from Barclays
TipRanks · 03/01 17:35
Tango Therapeutics Advances Cancer Treatment Pipeline
TipRanks · 02/28 05:12
More
About TNGX
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. Its lead program, TNG908, is an methylthioadenosine (MTA)-cooperative inhibitor of protein arginine methyltransferase 5 (PRMT5) designed to work selectively in cancer cells with an methylthioadenosine phosphorylase (MTAP) deletion. Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor. The Company's programs also include TNG348 and TNG462. TNG348 is an allosteric inhibitor of ubiquitin-specific protease (USP1).

Webull offers Tango Therapeutics Inc stock information, including NASDAQ: TNGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNGX stock methods without spending real money on the virtual paper trading platform.